Research output per year
Research output per year
Personal profile
Headline
ASSISTANT CLINICAL PROFESSOR, Medicine
Fingerprint
Dive into the research topics where Vivian Abascal, is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cardiac tumors: Updated classifications and main clinico-pathologic findings
Corradi, D., Moreno, P. R., Rahouma, M., Abascal, V. M., Guareschi, D., Tafuni, A., Grazioli, V., Palumbo, A., Niccoli, G. & Lorusso, R., Jul 2025, In: Trends in Cardiovascular Medicine. 35, 5, p. 297-308 12 p.Research output: Contribution to journal › Review article › peer-review
Open Access17 Scopus citations -
Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes
Pérez, M. S., Rodríguez-Capitán, J., Requena-Ibáñez, J. A., Santos-Gallego, C. G., Urooj Zafar, M., Escolar, G., Mancini, D., Mitter, S., Lam, D., Contreras, J. P., Fergus, I., Atallah-Lajam, F., Abascal, V., Lala, A., Moreno, P., Moss, N., Lerakis, S., Sanz, J., Fuster, V. & Badimon, J. J., Feb 2025, In: Cardiovascular Drugs and Therapy. 39, 1, p. 155-164 10 p.Research output: Contribution to journal › Review article › peer-review
16 Scopus citations -
Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction
EMPA-TROPISM (ATRU-4) Investigators, 26 Jan 2021, In: Journal of the American College of Cardiology. 77, 3, p. 243-255 13 p.Research output: Contribution to journal › Article › peer-review
Open Access433 Scopus citations -
Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the “Cardiac Benefits” of Empagliflozin Independent of its Hypoglycemic Activity?
Santos-Gallego, C. G., Garcia-Ropero, A., Mancini, D., Pinney, S. P., Contreras, J. P., Fergus, I., Abascal, V., Moreno, P., Atallah-Lajam, F., Tamler, R., Lala, A., Sanz, J., Fuster, V. & Badimon, J. J., 15 Feb 2019, In: Cardiovascular Drugs and Therapy. 33, 1, p. 87-95 9 p.Research output: Contribution to journal › Article › peer-review
53 Scopus citations -
Synopsis of an epidemiologic study of a Kentucky county in the Coronary Valley.
Abascal, V. M., Zielke, J. C., Spady, S. D., Mason, J. W. & Whayne, T. F., Nov 2008, In: Journal of the Kentucky Medical Association. 106, 11, p. 527-531 5 p.Research output: Contribution to journal › Article › peer-review
Press/Media
-
Study Findings on Heart Failure Are Outlined in Reports from Icahn School of Medicine at Mount Sinai [Rationale and Design of the Sota-p-cardia Trial (Atru-v): Sotagliflozin In Hfpef Patients Without Diabetes]
Lam, D., Abascal,, V., Moss, N., Mancini, D., Lam, D., Lerakis, S., Lala-Trindade,, A. & Badimon, J.
27/02/25
1 item of Media coverage
Press/Media
-
New Heart Failure Study Findings Have Been Reported by Investigators at Icahn School of Medicine at Mount Sinai [Rationale and Design of the Sota-p-cardia Trial (Atru-v): Sotagliflozin In Hfpef Patients Without Diabetes]
Lam, D., Abascal,, V., Moss, N., Mancini, D., Lam, D., Lerakis, S., Lala-Trindade,, A. & Badimon, J.
14/07/23
1 item of Media coverage
Press/Media